Four-year clinical experience with Ad Hoc fractional flow reserve measurement to guide ravascularization strategy  by Hodgson, John M. et al.
30A ABSTRACTS - Angiography & Interventional Cardiology JACC March 19,2003 
between FFR and CFVA a normal h-SRv (<1X60) was associated with a significantly 
lower MACE rate than an abnormal (ZI.80) SRv (14% vs. 42%. 95% confidence interval: 
1.05-7.72, p=O.O42). 
Conclusion: Discordant results between FFR and CFVR were documented in 30% of 
the lesions that underscores the need for combined measurements, as deferral of PTCA 
is associated with a high MACE rate. Furthermore, these results indicate that stenosis 
resistance index is a promising parameter for clmical decision making in lesions showing 
discordant results between FFR and CFVR. 
1077-200 Four-Year Clinical Experience With Ad Hoc Fractional 
Flow Reserve Measurement to Guide Revascularization 
Strategy 
John M. Hodason, Virgima Budzinski. Kathleen Quealy, Sorin J. Brener. Thomas Vrobel, 
MetroHealth Medical Center, Cleveland, OH, Case Western Reserve University, 
Cleveland, OH 
Background: Fractional flow reserve (FFR) has been proposed as a convenient way to 
assess intermediate lesion significance in the cath lab. Methods: We reviewed our 4 
year experience with the use of FFR (Wave wire, JOMED) performed ad hoc to assist in 
clinical patient management. Technical measurement factors and the influence on PCI 
were evaluated. Results: Between 6197 and 12/01 250 patients were evaluated (6.1% of 
cath volume). Use has grown from 3.9% of cases to >7% of cases. Mean visual lesion 
severity was 55%. No complications occurred. Overall, 80.4% of patients evaluated had 
PCI deferred in the tested lesion. Of these, 85.6% had medical treatment, 2.5% were 
referred to CABG and 11.9% had PCI in another vessel. In 19.6 % of patients, initial FFR 
led to PCI I” the tested lesion Patients received heparin (mean ACT 237*67) and intrac- 
oronary adenosine stimulus (mean 30+9.9mg. range 12-72). We attempted to use diag- 
nostic catheters whenever possible. Of the patients deferred, 69.7% were tested with a 
diagnostic catheter. The use of diagnostic catheters to measure FFR has increased over 
time from 64% to 75%. FFR had little impact on overall PCI volume. Even if all FFR 
cases were converted to PCI, the overall volume would have Increased only 7.5%. Ad- 
hoc FFR measurement allows optimal selection of revascularization strategy by defining 
the physiologic significance of intermediate lesions. While 2.5% of diagnostic cases were 
referred to CABG, as many as 9.6% of FFR cases may have been “converted’ from 
CABG to PCI. Conclusions: FFR may be rapidly measured ad-hoc using diagnostic 
catheters. Such a strategy allows deferral of unnecessary PCI in over 60% of lesions. 
Furthermore, traditional CABG candidates may be triaged to PCI if some of the potential 
target vessels are shown not to have hemodynamically significant lesions. 
-. 
1077-201 Microvascular Resistance in Addition to Stenosis 
Resistance Best Predicts Inducible Myocardial lschemie 
Mariiin Meuwissetj Steven A. Chamuleau, Bar?Jan Verhoeff, Maria Siebes, Jos A. 
Spaan, Jan G. Tijssen, Jan J. Piek, Academic Medical Center, Amsterdam, The 
Netherlands 
Background: Since ischemia is the result of insufficient perfusion of the relevant myo- 
cardial area we hypothesized that the sum of stenosis and minimal coronary microvascu- 
lar resistance is the best predictor of reversible ischemia. 
Methods: A total of 151 patients with stable angina with 181 coronary lesions were stud- 
ied. Pharmacological SPECT was performed to determme reversible defects in regions 
of interest. Distal coronary pressure and blood flow velocity were assessed during base- 
line and maximal hyperemia. Coronary stenosis resistance index (SRv) was defined as 
the ratio of hyperemic stenosis pressure gradient (mean aorta pressure-mean distal 
pressure) and hyperemlc average peak flow velocity (h-APV) and microvascular resis- 
tance index (h-MRv), was defined as the ratio of mean hyperemic distal pressure and h- 
APV. H-MRv was also determined in an angiographically normal coronary reference ves- 
sel (h-MAv-Ref). 
Results: The regions where categorized into four groups (based on the best cut off Value 
for SRv of 0.80 and 2.0 for MRv: median of ref-MRv): 1) MRV z-2 and SRV =-0.80,2) MRV 
~2 and SRV ,O.E, 3)MRV ~2 and SRV ~0.8 and 4) MRV ~2 and SRV >0.8. The predic- 
tive value of SRv and MRv for reversible ischemia is depicted in figure 1. 
Concl”sion: 
This study demonstrates the importance of microvascular resistance for the induction of 
myocardial ischemia. The likelihood for myocardial ischemta is high when both coronary 
and microvascular resistance are enhanced. 
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1077-202 The Angiographical Stenotic Flow Reserve Compared 
to lntracoronarv Hemodvnamic Parameters for 
Evaluation of Coronary Lesion Severity 
Jacobime J. Wiersma Mart@ Meuwissen, Steven A. Chamuleau, Maria Siebes, Johan 
H. Reiber, Jan G. Tijssen, Jan J. Piek, Academic Medical Center, Amsterdam, The 
Netherlands, Leiden University Medical Center. Leiden, The Netherlands 
BACKGROUND: Based on fluid dynamics equations and the geometry of coronary nar- 
rowings, quantitative coronary angiography (QCA) provides an estimate of coronary flow 
reserve (the stenotic flow reserve SFR). 
OBJECTIVE: A direct comparison between stenotic flow reserve and intra-coronary- 
derived coronary flow reserve parameters (fractional flow reserve (FFR) and coronary 
flow velocity reserve (CFVR)) for functional evaluation of coronary lesion severity as 
determined by sgm Tc MIBI-SPECT as a substudy of the ILIAS study Intermediate 
Lesions: Intracoronary-flow Assessment vs. 99m Tc MIBI-SPECT). METHODS: A total of 
187 patients with stable (CCS class 1-3) or unstable (Braunwald class I-II) angina under- 
went myocardial perfusion scintigraphy in a two day stress-rest protocol to determine 
reversible perfusion defects. Quantative coronary angiography was performed using the 
CMS-QCA software 3.32 (MEDIS, Leiden, the Netherlands) which includes the analysis 
of stenotlc flow reserve. FFR and CFVR were determined with guide wires distal to 291 
coronary lesions (mean diameter stenosis of 57%; range 31%.88%), during baseline and 
maximum hyperemia (induced by 15-20 mcg adenosine ic). Linear regression was per- 
formed to determine the relationship between stenotic flow reserve and FFR and CFVR. 
ROC-analysis was performed to determine the best cut off value of stenotic flow reserve 
and the predictive values of stenotic flow reserve, FFR and CFVR for the detection of 
reversible perfusion defects (by area under the curve, AUC). RESULTS: Linear ragres- 
sion showed moderate relations between stenotic flow reserve and FFR (?= 0.32, 
p<O.OOOl) and CFVR (&0.22, p<O.OOOl). The area under the curve of stenotic flow 
reserve was 0.78 +I- 0.04 with a best cut-off value of 2.3. The area under the curve of 
FFR and CFVR was 0.82 c/-0.03, 0.79 c/-O.03 respectively. 
CONCLUSION: Stenotic flow reserve has a moderate agreement with fractional and cor- 
onary flow reserve, while the predictive value of stenotic flow reserve for the presence of 
reversible perfusion defects is similar to the intracoronary derived hemodynamic parame- 
ters. 
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1078-177 Atherosclerotic Plaque and Dose Attenuation of 
Different Vascular Srachytherapy Sources: An Ex Vivo 
Dosimetry Study 
Paul Wexberq, Christian Kirisits, Daniel Berger. Irene Sulzbacher. Gerald Maurer, 
Dietmar Georg. Richard Potter, Dietmar Glogar, University of Vienna Medical Center, 
Vienna, Austria 
Background: Dose prescription and reportmg in vascular brachytherapy is based on the 
assumption that the vessel wall is water equivalent, which does not consider a possible 
dose perturbation by atherosclerotic plaque. The actual attenuation has never been mea- 
sured to our knowledge. 
Methods: SrN-90 and k-192 sources for vascular brachytherapy were fixed to an irradia- 
tion phantom embedded in water-equivalent gel in order to deliver a reference dose at 
2.5mm distance. The delivered doses from the source with and without human peripheral 
arteries surrounding the delivery catheter were read from the radiochromic films. Plaque 
and vessel wall thickness were measured from HE-stained vessel sections using light 
microscopy. We assessed 19 sections irradiated with SriY-90 and 7 sections irradiated 
with k-192. The attenuated dose was expressed as ratio of the reference dose, and this 
ratio was correlated with plaque thickness at the corresponding vessel section based on 
an exponential function. The attenuation coefficient of atherosclerotic plaque (VP) and of 
vessel wall (pW) was calculated by regression analysis. 
Results: The dose attenuation of beta-radiation correlated strongly with maximal plaque 
thickness (rz0.877, p<O.OOl), whereas we detected no correlation for gamma-radiation. 
The attenuation did no correlate with the thickness of the nondiseased vessel wall. pP for 
radiation delivered from SrN-90 was 0.61, pW was 0.03, whereas the attenuation of lr- 
192 was below the measurement uncertainties. In our calculation model a nondiseased 
arterial wall of lmm thickness results in a dose decrease of only 3%, whereas plaque of 
the same thickness increases the attenuation to 50%. 
Conclusions: Plaque thickness should be considered for future evaluation of dose pre- 
scrlption calculations in vascular brachytherapy with beta-radiation. 
